IFNG and inflammatory bowel disease: In this study, we demonstrated that hMuSCs treated with a combination of IFN-γ and TNF-α possess higher therapeutic efficacy on IBD than naïve hMuSCs, suggesting that tissue stem cells may generally exhibit an augmented immunomodulatory property in response to inflammatory cues.